Tamarack Advisers’s AngioDynamics ANGO Stock Holding History

Tamarack Advisers’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-475,000	Closed	-$3.47M	–	2
2023 Q3	$3.47M	Buy	475,000 +10,000	+2%	+$83.2K	2.25%	13
2023 Q2	$4.85M	Sell	465,000 -10,000	-2%	-$96.2K	1.5%	15
2023 Q1	$4.91M	Sell	475,000 -15,000	-3%	-$192K	1.8%	17
2022 Q4	$6.75M	Buy	490,000 +165,000	+51%	+$2.3M	3.47%	10
2022 Q3	$6.65M	Buy	325,000 +5,000	+2%	+$110K	3.9%	8
2022 Q2	$6.19M	Hold	320,000	–	–	3.58%	11
2022 Q1	$6.89M	Sell	320,000 -25,000	-7%	-$567K	3.26%	10
2021 Q4	$9.52M	Sell	345,000 -5,000	-1%	-$138K	3.91%	8
2021 Q3	$9.08M	Buy	350,000 +50,000	+17%	+$1.34M	2.87%	14
2021 Q2	$8.14M	Sell	300,000 -25,000	-8%	-$611K	2.31%	21
2021 Q1	$7.61M	Sell	325,000 -35,000	-10%	-$707K	1.56%	25
2020 Q4	$5.56M	Buy	+360,000	New	+$4.57M	1.16%	28

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tamarack Advisers's ANGO Position: Q4 2023 in Review

Tamarack Advisers sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 475,000 shares — an estimated $3.47M sold.

Tamarack Advisers first reported a position in ANGO in Q4 2020 and held it in 12 quarters. The position peaked at $9.52M in Q4 2021. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

Tamarack Advisers reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
Tamarack Advisers sold 475,000 AngioDynamics shares in Q4 2023, an estimated $3.47M.
Tamarack Advisers first reported a position in AngioDynamics in Q4 2020 and held it in 12 quarters.
Tamarack Advisers's AngioDynamics position peaked at $9.52M in Q4 2021.
150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Tamarack Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.